Your browser doesn't support javascript.
loading
A prospective phase IIA multicenter double-blinded randomized placebo-controlled clinical trial evaluating the efficacy and safety of inhaled Tobramycin in patients with ventilator-associated pneumonia (iToVAP).
Angermair, Stefan; Deja, Maria; Thronicke, Anja; Grehn, Claudia; Akbari, Nilufar; Uhrig, Alexander; Asgarpur, Golschan; Spies, Claudia; Treskatsch, Sascha; Schwarz, Carsten.
Affiliation
  • Angermair S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Berlin, Germany. Electronic address: Stefan.Angermair@charite.de.
  • Deja M; Department of Anesthesiology and Intensive Care Medicine, University of Schleswig-Holstein, Lübeck, Germany.
  • Thronicke A; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Social Medicine, Epidemiology and Health Economics, Charitéplatz 1, 10117 Berlin, Germany.
  • Grehn C; Berlin Institute of Health (BIH), Berlin, Germany.
  • Akbari N; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Biometry and Clinical Epidemiology, Charitéplatz 1, 10117 Berlin, Germany.
  • Uhrig A; Department of Infectious Diseases and Respiratory Medicine, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Asgarpur G; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Berlin, Germany.
  • Spies C; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Intensive Care Medicine, Campus Virchow, Berlin, Germany.
  • Treskatsch S; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Anesthesiology and Intensive Care Medicine, Campus Benjamin Franklin, Berlin, Germany.
  • Schwarz C; HMU-Health and Medical University, Klinikum Westbrandenburg Potsdam und Charite - Universitätsmedizin Berlin, Germany.
Anaesth Crit Care Pain Med ; 42(5): 101249, 2023 10.
Article in En | MEDLINE | ID: mdl-37217019

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Pneumonia, Ventilator-Associated Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Anaesth Crit Care Pain Med Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Pneumonia, Ventilator-Associated Type of study: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Anaesth Crit Care Pain Med Year: 2023 Type: Article